Evidence map›Paper›PMID 34752785›Full record

ArticleExperimental neurology2022

Modulation of gene expression on a transcriptome-wide level following human neural stem cell transplantation in aged mouse stroke brains.

Milton H Hamblin, Rabi Murad, Jun Yin, Gustavo Vallim, Jean-Pyo Lee

Open access · greenAbstract read
In one paragraph

Article in Experimental neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Stroke and vascular neurology · 2025
    Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Brain repair mechanisms after cell therapy for stroke.Brain : a journal of neurology · 2024
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Milton H HamblinTulane University Health Sciences Center, Tulane University, New Orleans, LA 70112, USA. Electronic address: mhambli@tulane.edu.
Rabi MuradBioinformatics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Jun YinBioinformatics, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.
Gustavo VallimDepartment of Physiology, Tulane University School of Medicine, New Orleans, LA 70112, USA.
Jean-Pyo LeeDepartment of Physiology, Tulane University School of Medicine, New Orleans, LA 70112, USA. Electronic address: jeanpyoL@tulane.edu.
Tulane University · USDiscovery Institute · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

Tumor Microenvironment and Cancer ImmunologyP30CA030199 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI Michael Jackson · 1985 to 2026
$107.2M
Combination treatment of ischemic stroke with perlecan DV and neural stem cellsR01NS110370 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI BIX, GREGORY JAYE, LEE, JEAN-PYO · 2019 to 2023
$2.4M
NCI NIH HHS P30 CA030199NINDS NIH HHS R01 NS110370
6 · The paper itself

Abstract

introductionNeural stem cell (NSC) transplantation offers great potential for treating ischemic stroke. Clinically, ischemia followed by reperfusion results in robust cerebrovascular injury that upregulates proinflammatory factors, disrupts neurovascular units, and causes brain cell death. NSCs possess multiple actions that can be exploited for reducing the severity of neurovascular injury. Our previous studies in young adult mice showed that human NSC transplantation during the subacute stage diminishes stroke pathophysiology and improves behavioral outcome.

methodsWe employed a well-established and commonly used stroke model, middle cerebral artery occlusion with subsequent reperfusion (MCAO/R). Here, we assessed the outcomes of hNSC transplantation 48 h post-MCAO (24 h post-transplant) in aged mouse brains in response to stroke because aging is a crucial risk factor for cerebral ischemia. Next, we tested whether administration of the integrin α5β1 inhibitor, ATN-161, prior to hNSC transplantation further affects stoke outcome as compared with NSCs alone. RNA sequencing (RNA-seq) was used to assess the impact of hNSC transplantation on differentially expressed genes (DEGs) on a transcriptome-wide level.

resultsHere, we report that hNSC-engrafted brains with or without ATN-161 showed significantly reduced infarct size, and attenuated the induction of proinflammatory factors and matrix metalloproteases. RNA-seq analysis revealed DEGs and molecular pathways by which hNSCs induce a beneficial post-stroke outcome in aged stroke brains. 811 genes were differentially expressed (651 downregulated and 160 upregulated) in hNSC-engrafted stroke brains. Functional pathway analysis identified enriched and depleted pathways in hNSC-engrafted aged mouse stroke brains. Depletion of pathways following hNSC-engraftment included signaling involving neuroinflammation, acute phase response, leukocyte extravasation, and phagosome formation. On the other hand, enrichment of pathways in hNSC-engrafted brains was associated with PPAR signaling, LXR/RXR activation, and inhibition of matrix metalloproteases. Hierarchical cluster analysis of DEGs in hNSC-engrafted brains indicate decreased expression of genes encoding TNF receptors, proinflammatory factors, apoptosis factors, adhesion and leukocyte extravasation, and Toll-like receptors.

conclusionsOur study is the first to show global transcripts differentially expressed following hNSC transplantation in the subacute phase of stroke in aged mice. The outcome of our transcriptome study would be useful to develop new therapies ameliorating early-stage stroke injury.

Indexed as

AgingAnimalsCells, CulturedCerebral InfarctionFetusGene Expression RegulationHumansMaleMiceMice, Inbred C57BLNeural Stem CellsOligopeptidesStem Cell TransplantationStrokeTranscriptomeacetyl-prolyl-histidyl-seryl-cysteinyl-asparaginamideOligopeptidesBlood-brain barrierInflammationIngenuity pathway analysisNeural stem cellsRNA sequencingStem cell transplantationStrokeTranscriptome

Identifiers

PMID34752785
PMCPMC8647207
OpenAlexW3211627129

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.